Orbimed Advisors LLC Wave Life Sciences Ltd. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Orbimed Advisors LLC holds 180,000 shares of WVE stock, worth $2.37 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
180,000Holding current value
$2.37 Million% of portfolio
0.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$240 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$133 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$128 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$88.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$81.3 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.15B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...